Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants

NCT07744802 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Participants

Interventions

DRUG: Vimseltinib
DRUG: Dabigatran

Sponsor

Deciphera Pharmaceuticals, LLC